UV Light Exposure May Be Inversely Associated With Hodgkin Lymphoma
Hodgkin lymphoma incidence was lower in areas of the United States with more ultraviolet radiation exposure.
Hodgkin lymphoma incidence was lower in areas of the United States with more ultraviolet radiation exposure.
Patients with advanced-stage Hodgkin lymphoma who were at high risk for treatment failure as determined by interim PET response.
Standard ABVD was associated with a significant improvement in survival in older patients with Hodgkin lymphoma.
Significant disparities have been found in HIV-positive black patients with Hodgkin lymphoma, with regard to both rate of diagnosis and chemotherapy usage.
Patients with advanced Hodgkin lymphoma treated with BEACOPP or CEC did not show a progression-free survival.
Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.
Involved-field radiotherapy (IF-RT) should be considered standard of care for stage 1A nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).
Recent declines in nodular sclerosis (NS) rates represented true incidence changes in Hodgkin lymphoma (HL).
For Hodgkin’s lymphoma, brentuximab vedotin is associated with improved progression-free survival after autologous stem-cell transplant.
PET-adapted sequential salvage therapy with brentuximab could optimize chance of cure in relapsed and refractory Hodgkin lymphoma.